ABT vs BTSG: fair value comparison
Abbott Laboratories and BrightSpring Health Services, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ABT currently sits closer to the top of our discount ranking. ABT carries the stronger quality grade.
| ABT | BTSG | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $112.47 | $60.47 |
| 12-month range | $87.78–$131.46 | $23.88–$69.85 |
| Sector rank | #43 of 113 Healthcare | #44 of 113 Healthcare |
| Quality grade | B | D |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | Overvalued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: ABT fair value analysis · BTSG fair value analysis